about
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine.Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stressAcute blood pressure responses in healthy adults during controlled air pollution exposuresAsymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosisCellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesAsymmetric dimethyarginine as marker and mediator in ischemic strokeZn(II)-free dimethylargininase-1 (DDAH-1) is inhibited upon specific Cys-S-nitrosylationIncreased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferasesStructural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain. Zn(II) release activates DDAH-1.Amino acid transport in thermophiles: characterization of an arginine-binding protein in Thermotoga maritima. 2. Molecular organization and structural stability.Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasiaCapillary electrophoretic and micellar electrokinetic separations of asymmetric dimethyl-L-arginine and structurally related amino acids: quantitation in human plasma.Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening.Endothelial nitric oxide synthase transgenic models of endothelial dysfunctionFlow, NO, and atherogenesisPost-prandial hypertriglyceridemia and endothelium-dependent vasorelaxation.Nitric oxide donor drugs: current status and future trends.Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury.Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palateRegulation of amino acid and glucose transporters in endothelial and smooth muscle cells.L-arginine in cardiovascular disease: dream or reality?Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia.Endothelial cell metabolism in normal and diseased vasculature.Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reservePharmacological effects of xanthones as cardiovascular protective agents.Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.Left ventricular diastolic dysfunction and plasma asymmetric dimethylarginine concentration in persons with essential hypertensionSustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease.The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis.Plasma ADMA associates with all-cause mortality in renal transplant recipients.Mechanisms underlying endothelial dysfunction in diabetes mellitus: therapeutic implications.Targeting endothelial dysfunction in hypertensive subjects.Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients.Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distressEndothelial function and its assessment.Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.
P2860
Q21245073-7FAA1956-5E9E-4FAD-B382-862682E802F2Q24805294-7D8797C7-0D6B-463C-AA06-8783E9E15CE6Q24815292-D21E4610-77E9-44AA-8A76-147178EDF37FQ26795604-7B12FF81-CE58-4F9D-9ACA-68AC1502F178Q26798487-7AB229F4-C12C-4B9C-A2E5-D9556ECA5AFEQ26864318-90B7C2A0-0919-4579-AB8A-A455BD6246F2Q28590295-0F56AAF5-9BB5-4CEC-99B0-EABDF6F17BE9Q28594903-33EBF495-3E04-4B6F-870E-44AA3CF8FCE0Q30328626-6BEA394E-35E8-4AF1-84D4-299AE7E5F84DQ30386805-93F663E9-0F28-4D2B-BAC6-2E2CA473348BQ30430542-9FCF07B3-5B4B-46E7-A22A-B1CCF5923EA6Q31139539-FC692110-B712-4E3A-B59F-E875B87227EDQ33589158-8A4DA9C9-B7D1-49E8-BB3F-B6AC23D83334Q33891755-83014000-9F02-4D09-A8CC-AD798EC8D5D9Q34213198-BF598FD6-6B7F-48D2-8629-985DAB622060Q34286604-5C85C48D-0FE6-4555-B05A-50C5D9697CF6Q34327487-9145C991-9D2E-44EE-9E11-A4F8F91A1573Q34570622-D69D8FF7-55AD-447B-BF5C-93834A1337C8Q34628644-61F1E092-5EBC-4FF5-925E-2ACCC09CB3B7Q34794828-1DCB62A0-1461-4A22-9820-C05B19826FB2Q34983609-F79D0EAB-2033-42ED-AE44-23D44018852BQ35035933-2EF37E21-5C91-49F0-8673-D0BC8C834753Q35055189-6D7DBA65-C3DE-4E7E-AC05-29853C9D169CQ35075847-3F045320-78CE-4781-8BA3-596AEF7CE44DQ35118290-8B154A33-C0D0-4D82-BDBE-C525B17EF733Q35234625-BAE86502-8C86-4C90-8D95-CCC8C254720BQ35585000-FA8206E9-DEDE-4AB9-B178-8068A6EB01A2Q35793189-21E2CA6C-EF63-40CF-B34E-CBF1EA09B4C2Q35801877-F2178602-A371-4331-9E24-98B1F448E75EQ35829220-37B115C6-3ABA-4698-AA63-54BAE97AA76DQ35859291-4CA6E2AA-8032-464F-A911-7E4382BC1B91Q35888589-52E8ACE0-F78D-47D5-A643-18F64A6C28AAQ35995894-6FCD7F70-085E-4F60-B299-5038742D7326Q36176310-A3DD8453-CA56-4447-BB23-0105BFC40A96Q36216260-BC4483C1-1E45-48DD-9538-B5E31743E204Q36273319-DB9FF2D2-89FC-4558-A1ED-05194CBABB4CQ36273357-0B69FD87-112D-4D4B-95F3-552345DBCFF2Q36274244-5EAD2418-DC02-448D-B1ED-CE9ED0009308Q36300017-7795DC4E-368F-4A62-B018-621091711E2BQ36481807-F09AFB8C-06EB-48EC-8FFC-53ABE44E80A4
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Does ADMA cause endothelial dysfunction?
@ast
Does ADMA cause endothelial dysfunction?
@en
Does ADMA cause endothelial dysfunction?
@nl
type
label
Does ADMA cause endothelial dysfunction?
@ast
Does ADMA cause endothelial dysfunction?
@en
Does ADMA cause endothelial dysfunction?
@nl
prefLabel
Does ADMA cause endothelial dysfunction?
@ast
Does ADMA cause endothelial dysfunction?
@en
Does ADMA cause endothelial dysfunction?
@nl
P356
P1476
Does ADMA cause endothelial dysfunction?
@en
P2093
P304
P356
10.1161/01.ATV.20.9.2032
P407
P577
2000-09-01T00:00:00Z